SHARON ADAMS: Open Payments
NPI 1821324278 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,542 in 148 payments from 17 companies in 2025. Trend: 2023 $1,671 · 2024 $2,283 · 2025 $2,542
Food & beverage: $2,439Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $563 |
| Phathom Pharmaceuticals, Inc. | 37 | $360 |
| Janssen Biotech, Inc. | 13 | $290 |
| Madrigal Pharmaceuticals | 8 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $182 |
| Regeneron Healthcare Solutions, Inc. | 7 | $157 |
| Aimmune Therapeutics, Inc. | 10 | $147 |
| QOL Medical, LLC | 5 | $120 |
| Lilly USA, LLC | 5 | $97 |
| GENZYME CORPORATION | 5 | $95 |
Products named: VOQUEZNA, TREMFYA, REZDIFFRA, DUPIXENT, RINVOQ, LINZESS, ENTYVIO, ZENPEP.
Industry payments across KY — which companies pay providers there.
